which then potently suppressed inflammation in this mouse model of neutrophilic asthma. More information: Vijay Raaj Ravi et ...
Medically reviewed by Daniel More, MD Managing your allergic asthma requires a comprehensive approach. There are no proven ...
The researchers demonstrated that they could treat a mouse model of severe allergic asthma using either a combination of an ICOSL and OX40L inhibitor—or an ICOSL and CD30L inhibitor. The ...
Asthma is a heterogeneous disorder ... In conclusion, we demonstrate that TNFα reduces the responsiveness to GCs in a mouse model of neutrophilic airway inflammation. Thus antagonizing TNFα ...